Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated July 26, 2023.26-07-2023
Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release dated July 26, 2023.Syngene International Ltd - 539268 - Board Meeting Outcome for Outcome Of The Board Meeting - June 30, 2023.
Outcome of the Board Meeting - June 30, 2023.Syngene International Ltd - 539268 - Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2023.
Unaudited Financial Results for quarter ended June 30, 2023.Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the intimation for conference call for Analysts and Investors to be held on Thursday, July 27, 2023.Syngene International Ltd - 539268 - Board Meeting Intimation for Considering And Approving The Unaudited Standalone And Consolidated Financial Results For The Quarter Ended On June 30, 2023, Along With Other Items.
Syngene International Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2023 ,inter alia, to consider and approve the unaudited standalone and consolidated financial results for the quarter ended on June 30, 2023.Syngene International Ltd - 539268 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Reg. 74(5) of SEBI (Depositories and Participants) Regulations, 2018.Syngene International Ltd - 539268 - Business Responsibility and Sustainability Reporting (BRSR)
Pursuant to Regulation 34(2)(f) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are hereby enclosing the Business Responsibility and Sustainability Report ("BRSR") for the Financial Year 2022-23, which also forms part of the Annual Report for the Financial year 2022-23.Syngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Newspaper Publication
We wish to inform you that the Company has completed dispatching of Notice of the 30th AGM and Annual Report 2022-23 through email on July 4,2023 to eligible members who have registered their email ID''s with the Company / Depository Participant(s) . Please find enclosed the copies of the newspaper advertisement published in Financial Express (English language) on July 5,2023 and Vijayavani, Bengaluru edition (Kannada Language) on July 5,2023.Syngene to acquire Unit 3 biologics manufacturing site for gross value of 702 cr
The facility is being repurposed to manufacture monoclonal antibodies; Syngene to further invest up to 100 crore to repurpose and revalidate the facilitySyngene International Ltd - 539268 - Reg. 34 (1) Annual Report.
We wish to inform you that the 30th AGM of the company will be held on Wednesday, July 26, 2023 at 3:30 pm (IST) through Video Conferencing ("VC")/ Other Audio Visual Means ("OAVM"). In this regard and in compliance with the Regulation 34 of the SEBI (LODR) Regulations, 2015, please find enclosed the notice of the 30th AGM of the company and the Annual report for FY 2022- 2023, which is being circulated to the shareholders through electronic mode.